| NCT Number | NCT07009405 |
| Lead Sponsor | Rhaeos, Inc. |
| Conditions | IV Infiltration, IV Extravasation |
| Enrollment | 10 participants |
| Start Date | 2025-05-28 |
| Primary Completion | 2025-12 (estimated) |
| Study Completion | 2025-12 (estimated) |
| Updated on ClinicalTrials.gov | 2025-06-06 |